Discovery of N-aryl-naphthylamines as in vitro inhibitors of the interaction between HIV integrase and the cofactor LEDGF/p75
摘要:
A series of N-aryl-naphthylamines, exemplified by the structures 11-16, were chosen for an in-house library screening to assay their ability to disrupt the interaction between the LEDGF cofactor and the HIV integrase. Structure modification led also to design and synthesize new compounds 17a-f. Compounds 11e,h,k,n, 13b, and 14 showed good activity in AlphaScreen assay. The most active compound lie (IC50 = 2.5 mu M) was selected for molecular modeling studies and showed a binding mode similar to the one of the known LEDGIN 8. (C) 2015 Elsevier Masson SAS. All rights reserved.
Discovery of N-aryl-naphthylamines as in vitro inhibitors of the interaction between HIV integrase and the cofactor LEDGF/p75
摘要:
A series of N-aryl-naphthylamines, exemplified by the structures 11-16, were chosen for an in-house library screening to assay their ability to disrupt the interaction between the LEDGF cofactor and the HIV integrase. Structure modification led also to design and synthesize new compounds 17a-f. Compounds 11e,h,k,n, 13b, and 14 showed good activity in AlphaScreen assay. The most active compound lie (IC50 = 2.5 mu M) was selected for molecular modeling studies and showed a binding mode similar to the one of the known LEDGIN 8. (C) 2015 Elsevier Masson SAS. All rights reserved.
A series of N-aryl-naphthylamines, exemplified by the structures 11-16, were chosen for an in-house library screening to assay their ability to disrupt the interaction between the LEDGF cofactor and the HIV integrase. Structure modification led also to design and synthesize new compounds 17a-f. Compounds 11e,h,k,n, 13b, and 14 showed good activity in AlphaScreen assay. The most active compound lie (IC50 = 2.5 mu M) was selected for molecular modeling studies and showed a binding mode similar to the one of the known LEDGIN 8. (C) 2015 Elsevier Masson SAS. All rights reserved.